Skip to main content
. 2015 Sep 24;18(3):271–278. doi: 10.4048/jbc.2015.18.3.271

Figure 1. Study design.

Figure 1

IDC=invasive ductal carcinoma; ILC=invasive lobular carcinoma; ER=estrogen receptor; PR=progesterone receptor; HER2=human epidermal growth factor receptor 2; CMF=cyclophosphamide, methotrexate, and 5-fluorouracil; FAC=5-fluorouracil, anthracycline, and cyclophosphamide; AC=anthracycline and cyclophosphamide.